CA2460947A1 - 6-o-carbamate-11,12-lacto-ketolide antimicrobials - Google Patents

6-o-carbamate-11,12-lacto-ketolide antimicrobials Download PDF

Info

Publication number
CA2460947A1
CA2460947A1 CA002460947A CA2460947A CA2460947A1 CA 2460947 A1 CA2460947 A1 CA 2460947A1 CA 002460947 A CA002460947 A CA 002460947A CA 2460947 A CA2460947 A CA 2460947A CA 2460947 A1 CA2460947 A1 CA 2460947A1
Authority
CA
Canada
Prior art keywords
mmol
compound
reference example
substituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002460947A
Other languages
English (en)
French (fr)
Inventor
Eugene B. Grant, Iii
Todd C. Henninger
Mark J. Macielag
Deodialsingh Guiadeen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2460947A1 publication Critical patent/CA2460947A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002460947A 2001-09-17 2002-09-16 6-o-carbamate-11,12-lacto-ketolide antimicrobials Abandoned CA2460947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32276201P 2001-09-17 2001-09-17
US60/322,762 2001-09-17
PCT/US2002/029314 WO2003024986A1 (en) 2001-09-17 2002-09-16 6-o-carbamate-11,12-lacto-ketolide antimicrobials

Publications (1)

Publication Number Publication Date
CA2460947A1 true CA2460947A1 (en) 2003-03-27

Family

ID=23256294

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002460947A Abandoned CA2460947A1 (en) 2001-09-17 2002-09-16 6-o-carbamate-11,12-lacto-ketolide antimicrobials

Country Status (6)

Country Link
US (1) US6713455B2 (cg-RX-API-DMAC7.html)
EP (1) EP1430068A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005503416A (cg-RX-API-DMAC7.html)
CN (1) CN1589277A (cg-RX-API-DMAC7.html)
CA (1) CA2460947A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003024986A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004531471A (ja) * 2000-12-21 2004-10-14 グラクソ グループ リミテッド マクロライド抗生物質
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
WO2008014221A2 (en) * 2006-07-24 2008-01-31 Enanta Pharmaceuticals, Inc. Bridged carbamate macrolides
ES2428874T3 (es) 2006-08-09 2013-11-12 Basilea Pharmaceutica Ag Nuevos macrólidos útiles contra las enfermedades inflamatorias y alérgicas
US8410065B2 (en) 2008-02-08 2013-04-02 Basilea Pharmaceutica Ag Macrolides and their use
JP5744021B2 (ja) 2010-06-30 2015-07-01 富士フイルム株式会社 新規なニコチンアミド誘導体またはその塩
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5559256A (en) 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
MX9604368A (es) 1994-03-28 1997-12-31 Ciba Geigy Japan Ltd Antagonistas de receptores de endotelina.
PT876388E (pt) 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica
EP0891355A1 (en) 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
DE69733439T2 (de) 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
WO1999002524A1 (en) 1997-07-08 1999-01-21 Sankyo Company, Limited Antifungal triazole compounds
CO4990972A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de eritromicina en puente 6,11
CO4990960A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
ATE250076T1 (de) 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
EP1114826A3 (en) 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
MXPA03001607A (es) * 2000-08-22 2003-06-04 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.
GB0031312D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
EP1430068A1 (en) 2004-06-23
CN1589277A (zh) 2005-03-02
US20030125267A1 (en) 2003-07-03
WO2003024986A1 (en) 2003-03-27
JP2005503416A (ja) 2005-02-03
US6713455B2 (en) 2004-03-30

Similar Documents

Publication Publication Date Title
US6472372B1 (en) 6-O-Carbamoyl ketolide antibacterials
US6054435A (en) 6-O-substituted macrolides having antibacterial activity
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
US5932710A (en) Process for preparing 6-O-alkyl-9-oxime erythromycin B
EP1027362B1 (en) 2-halo-6-o-substituted ketolide derivatives
US6713455B2 (en) 6-O-carbamate-11,12-lacto-ketolide antimicrobials
US5780605A (en) 6,9-bridged erythromycin derivatives
JP2002539217A (ja) 抗菌活性を有する6−o−置換マクロライド
WO1999016779A1 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
US6825170B2 (en) 6-O-acyl ketolide antibacterials
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6825172B2 (en) 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
WO2006047167A2 (en) 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
US6667338B2 (en) 9-amino erythromycin derivatives with antibacterial activity
US20020132782A1 (en) 9-amino erythromycin derivatives with antibacterial activity
US20050250713A1 (en) 11,12-Cyclic thiocarbamate macrolide antibacterial agents
MXPA00003117A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
HK1031383B (en) 2-halo-6-o-subsituted ketolide derivatives

Legal Events

Date Code Title Description
FZDE Discontinued